{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T12:22:23Z","timestamp":1777465343970,"version":"3.51.4"},"reference-count":32,"publisher":"Georg Thieme Verlag KG","issue":"03","license":[{"start":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T00:00:00Z","timestamp":1663632000000},"content-version":"vor","delay-in-days":2210,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Asian J Neurosurg"],"published-print":{"date-parts":[[2016,9]]},"abstract":"<jats:p>\n          Context: Functional growth hormone producing adenomas have long-term deleterious effects on the visual apparatus, the cardiovascular and musculoskeletal systems, and often predispose to malignancies. Since persistence of acromegaly affects outcome and quality of life, therapeutic interventions become mandatory. Aim: This study represents an analysis of long-term clinical and endocrinal outcome of 115 patients of acromegaly after surgical management.\nSetting and Design: Tertiary care retrospective study. Materials and Methods: One hundred and fifteen patients (male:female ratio: 1:1.09) with acromegalic features were studied. Apart from acromegalic features, their main clinical presentation also included headache, diminution of vision, field defects, ptosis, irregular menstruation, diabetes insipidus, diabetes mellitus and hypertension. Six of them presented with apoplexy. Their preoperative endocrinal evaluation included basal and suppressed growth hormone (GH), prolactin and thyroid levels. On the basis of axial and coronal CT scan or multiplanar MR imaging or both, the tumors were classified according to their suprasellar and parasellar extension (Hardy's grade). Transnasal trans-sphenoidal surgery (TSS) (n = 37) and sublabial, rhinoseptal TSS (n = 72) were the preferred approaches. Six patients with significant parasellar extensions underwent trans-cranial explorations. The patients were followed up at 6 and 12 weeks and then at 6 monthly intervals. Hormonal and CT\/MR evaluation were also done. Attainment of random GH value less than 2.5 \u00b5g\/L, and the nadir GH value after oral glucose tolerance test (OGTT) less than 1 \u00b5g\/L were used as the criteria of cure.\nFindings: The patients were preoperatively in Hardy's tumor grade 0 (29), A (21), A+E (3), B (21), B+E (5), C (9), C+E (10), D (1) D+E (11), E (5), respectively. One hundred and one patients were available for follow-up (FU; median FU duration: 84 months; range: 6 to 132 months). Surgical cure was achieved in 73 patients following the first surgery; and, in 10 additional patients following a second intervention. No patient with a preoperative grade 0, A, B, C had a recurrence after attaining the initial remission. Recurrence after an initial cure occurred in 7 patients (overall remission rate following surgery: 75.24%). The preoperative grade of the latter patients was A+E:1, B+E:1, C+E:1, D:1, D+E:2, E:1, respectively. All these patients underwent subsequent radiotherapy (RT). The twelve patients with persistent symptoms and high GH levels following surgery underwent RT; six others with improved symptoms despite high GH levels were kept under strict observation. There was no surgical mortality. Conclusions: A high remission rate without significant morbidity could be achieved following surgical intervention in acromegalic patients. Following surgery, tumors with greater than or equal to 3 cm suprasellar height and without parasellar extension had no clinical recurrence at FU. A continuous monitoring is mandatory to pick up relapsed cases as well as those who develop delayed signs of hypopituitarism. A subset of patients who show clinical improvement following surgery but still have higher GH levels may be followed up without additional therapy unless clinical signs reappear or the serum GH levels progressively increase.<\/jats:p>","DOI":"10.4103\/1793-5482.145354","type":"journal-article","created":{"date-parts":[[2014,11,25]],"date-time":"2014-11-25T06:07:26Z","timestamp":1416895646000},"page":"261-267","source":"Crossref","is-referenced-by-count":8,"title":["Surgical management of acromegaly: Long term functional outcome analysis and assessment of recurrent\/residual disease"],"prefix":"10.1055","volume":"11","author":[{"given":"Deepu","family":"Banerji","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nitu","family":"Das","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siddhiraj","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yogesh","family":"Jindal","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijendra","family":"Jain","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Behari","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2022,9,20]]},"reference":[{"key":"key-10.4103\/1793-5482.145354-1","first-page":"966","volume-title":"Acromegaly","author":"Melmed","year":"1990","journal-title":"N Engl J Med"},{"key":"key-10.4103\/1793-5482.145354-2","first-page":"185","volume-title":"Long-term treatment outcome in acromegaly","author":"Holdaway","year":"2003","journal-title":"Growth Horm IGF Res"},{"key":"key-10.4103\/1793-5482.145354-3","first-page":"75","volume-title":"GH and mortality in acromegaly","author":"Sheppard","year":"2005","journal-title":"J Endocrinol Invest"},{"key":"key-10.4103\/1793-5482.145354-4","first-page":"1","volume-title":"Mortality in acromegaly","author":"Wright","year":"1970","journal-title":"Q J Med"},{"key":"key-10.4103\/1793-5482.145354-5","first-page":"157","volume-title":"Efficacy and complications of neurosurgical treatment of acromegaly","author":"Krzentowska-Korek","year":"2011","journal-title":"Pituitary"},{"key":"key-10.4103\/1793-5482.145354-6","first-page":"213","volume-title":"AACE Medical Guidelines for Clinical Practice for the diagnosis and treatment of acromegaly","author":"Cook","year":"2004","journal-title":"Endocr Pract"},{"key":"key-10.4103\/1793-5482.145354-7","first-page":"237","volume-title":"Transsphenoidal and transcranial surgery for pituitary adenomas","author":"Couldwell","year":"2004","journal-title":"J Neurooncol"},{"key":"key-10.4103\/1793-5482.145354-8","first-page":"669","volume-title":"Surgical management of acromegaly","author":"Fahlbusch","year":"1992","journal-title":"Endocrinol Metab Clin North Am"},{"key":"key-10.4103\/1793-5482.145354-9","first-page":"517","volume-title":"The Birmingham pituitary database: Auditing the outcome of the treatment of acromegaly","author":"Jenkins","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key-10.4103\/1793-5482.145354-10","first-page":"723","volume-title":"Microscope and endoscopic pituitary surgery","author":"Powell","year":"2009","journal-title":"Acta Neurochir (Wien)"},{"key":"key-10.4103\/1793-5482.145354-11","first-page":"526","volume-title":"Criteria for cure of acromegaly: A consensus statement","author":"Giustina","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/1793-5482.145354-12","first-page":"4072","volume-title":"Surgical management of GH-secreting pituitary adenomas: An outcome study using modern remission criteria","author":"Kreutzer","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"key-10.4103\/1793-5482.145354-13","first-page":"407","volume-title":"Outcome of transsphenoidal surgery using strict criteria for surgical cure","author":"Sheaves","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key-10.4103\/1793-5482.145354-14","first-page":"353","volume-title":"Long-term endocrinological follow-up evaluation in 115 patients who underwent transsphenoidal surgery for acromegaly","author":"Freda","year":"1998","journal-title":"J Neurosurg"},{"key":"key-10.4103\/1793-5482.145354-15","first-page":"531","volume-title":"A comparison of different methods for diagnosing acromegaly","author":"Stoffel-Wagner","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key-10.4103\/1793-5482.145354-16","first-page":"200","volume-title":"Dynamic tests and basal values for defining active acromegaly","author":"Tzanela","year":"2006","journal-title":"Neuroendocrinology"},{"key":"key-10.4103\/1793-5482.145354-17","unstructured":"Hardy J, Vezina JL. Transsphenoidal neurosurgery of intracranial neoplasm. In: Tompson RA, Green JR, editors. Advances in Neurology. New York: Raven Press; vol 15, 1976. p. 261-75."},{"key":"key-10.4103\/1793-5482.145354-18","unstructured":"Wilson CB. Neurosurgical management of large and invasive pituitary tumors. In: Tindall GT, Collins WF, editors. Clinical management of pituitary disorders. New York: Raven Press; 1979. p. 335-42."},{"key":"key-10.4103\/1793-5482.145354-19","first-page":"284","volume-title":"Clinical, quality of life, and economic value of acromegaly disease control","author":"Ben-Shlomo","year":"2011","journal-title":"Pituitary"},{"key":"key-10.4103\/1793-5482.145354-20","first-page":"26","volume-title":"A prospective analysis of 151 cases of patients with acromegaly operated by one neurosurgeon: A follow-up of more than 23 years","author":"Abbassioun","year":"2006","journal-title":"Surg Neurol"},{"key":"key-10.4103\/1793-5482.145354-21","first-page":"379","volume-title":"The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical 'cure'","author":"Nomikos","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"key-10.4103\/1793-5482.145354-22","first-page":"617","volume-title":"Factors determining the long-term outcome of surgery for acromegaly","author":"Osman","year":"1994","journal-title":"QJM"},{"key":"key-10.4103\/1793-5482.145354-23","first-page":"366","volume-title":"Early postoperative indicators of late outcome in acromegalic patients","author":"Takahashi","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key-10.4103\/1793-5482.145354-24","first-page":"653","volume-title":"The outcome of surgery for acromegaly: The need for a specialist pituitary surgeon for all types of growth hormone (GH) secreting adenoma","author":"Lissett","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key-10.4103\/1793-5482.145354-25","first-page":"854","volume-title":"Results of transsphenoidal microsurgery for growth hormone-secreting pituitary adenoma in a series of 214 patients","author":"Ross","year":"1988","journal-title":"J Neurosurg"},{"key":"key-10.4103\/1793-5482.145354-26","first-page":"205","volume-title":"Transsphenoidal adenomectomy for growth hormone-secreting pituitary adenomas in acromegaly: Outcome analysis and determinants of failure","author":"Tindall","year":"1993","journal-title":"J Neurosurg"},{"key":"key-10.4103\/1793-5482.145354-27","first-page":"243","volume-title":"Treatment outcomes and mortality of 94 patients with acromegaly","author":"Trepp","year":"2005","journal-title":"Acta Neurochir (Wien)"},{"key":"key-10.4103\/1793-5482.145354-28","first-page":"277","volume-title":"Acromegaly, diagonosis and therapy","author":"Barkan","year":"1989","journal-title":"Endocrinol Metab Clin North Am"},{"key":"key-10.4103\/1793-5482.145354-29","first-page":"561","volume-title":"Outcome of transsphenoidal surgery for acromegaly and relationship to surgical experience","author":"Ahmed","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key-10.4103\/1793-5482.145354-30","first-page":"693","volume-title":"Radiation therapy of acromegaly","author":"Eastman","year":"1992","journal-title":"Endocrinol Metab Clin North Am"},{"key":"key-10.4103\/1793-5482.145354-31","first-page":"345","volume-title":"Stereotactic radiosurgery for pituitary adenomas: A comprehensive review of indications, techniques and long-term results using the Gamma Knife","author":"Jagannathan","year":"2009","journal-title":"J Neurooncol"},{"key":"key-10.4103\/1793-5482.145354-32","first-page":"1","volume-title":"Stereotactic radiosurgery for hypersecreting pituitary tumors: Part of a multimodality approach","author":"Jane","year":"2003","journal-title":"Neurosurg Focus"}],"container-title":["Asian Journal of Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.4103\/1793-5482.145354.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T23:06:43Z","timestamp":1663715203000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.4103\/1793-5482.145354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":32,"journal-issue":{"issue":"03","published-online":{"date-parts":[[2022,9,20]]},"published-print":{"date-parts":[[2016,9]]}},"URL":"https:\/\/doi.org\/10.4103\/1793-5482.145354","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1793-5482","2248-9614"],"issn-type":[{"value":"1793-5482","type":"print"},{"value":"2248-9614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9]]}}}